Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Starting Dose and Titration Schedule Retatrutide phase 2 used a structured titration: Weeks 1 to 4: 2 mg subcutaneous once weekly Weeks 5 to 8: 4 mg once weekly Weeks 9 to 12: 8 mg once weekly Week 13 onward: 12 mg once weekly (maximum dose) Gastrointestinal adverse events drove dose reductions in 15.7% of participants receiving 12 mg in the phase 2 trial
Store the lyophilized peptide refrigerated until use
It stocks your mitochondria up with fat that is metabolized to produce ATP energy for the body and help you operate at your peak and support your weight management goals
In addition, weight loss is a consistent finding in clinical trials investigating GLP-1RAs ( Reduction of hepatic and adipose tissue insulin resistance An improved insulin sensitivity is expected after chronic treatment with GLP-RAs mainly due to marked bodyweight reductions
This formulation is a dual peptide blend combining TB-500 and BPC-157, designed for laboratory research involving peptide signaling pathways and cellular interaction models
.jpg)
